Publicaciones en colaboración con investigadoras/es de Hospital Vall d'Hebron (24)

2022

  1. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina Intensiva

  2. Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia

    Medicina intensiva, Vol. 46, Núm. 8, pp. 426-435

2017

  1. EPICO 4.0. ‘Total quality’ in the management of invasive candidiasis in critically ill patients by analysing the integrated process

    Revista Iberoamericana de Micologia, Vol. 34, Núm. 3, pp. 143-157

  2. Impact of a multifaceted educational intervention including serious games to improve the management of invasive candidiasis in critically ill patients

    Medicina Intensiva, Vol. 41, Núm. 1, pp. 3-11

2015

  1. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

2011

  1. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

  2. Posaconazole susceptibility of clinical yeast isolates determined by an agar diffusion and microdilution method

    International Journal of Antimicrobial Agents

  3. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

  4. Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update

    Enfermedades Infecciosas y Microbiologia Clinica

2010

  1. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 122-125

2008

  1. Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with neo-sensitabs tablets

    Chemotherapy, Vol. 54, Núm. 1, pp. 38-42

  2. Latest developments in fungal lung infection in solid organ transplantation (SOT)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. SUPPL. 3, pp. 49-57

2006

  1. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One™

    Mycoses, Vol. 49, Núm. 4, pp. 293-297

2005

  1. Amphotericin B colloidal dispersion. Survey of in vitro antifungal activity. Antifungal activity of Amphocil®, amphotericin B and fluconazole

    Mikologia Lekarska, Vol. 12, Núm. 1, pp. 5-10

  2. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

    Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 3, pp. 317-319

  3. In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis

    Revista Iberoamericana de Micologia, Vol. 22, Núm. 2, pp. 110-113

2004

  1. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: Comparison of the sensititre yeast one® and NCCLS M38-A reference methods

    Journal of Chemotherapy, Vol. 16, Núm. 5, pp. 468-473

  2. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis

    Chemotherapy, Vol. 50, Núm. 6, pp. 308-313

  3. ¿Es activa la amfotericina B frente a hongos dermatófitos y Scopulariopsis brevicaulis?

    Revista Espanola de Quimioterapia, Vol. 17, Núm. 3, pp. 244-249